Coherus Oncology, Inc.

Coherus Oncology, Inc. Estimates – NASDAQ:CHRS
TradingView · 23 Oct 2026
Coherus schedules October 28 webcast for Coherus Oncology stock
AD HOC NEWS · 20 Oct 2026
Coherus Oncology schedules October 28 webcast for Coherus Oncology stock
AD HOC NEWS · 17 Oct 2026
Coherus Oncology stock sits at EUR 0.93 with a price-to-earnings ratio of -1.02
ad-hoc-news.de · 15 Oct 2026
Coherus Oncology to release interim clinical da...
Pluang · 14 Oct 2026
A cancer drug is being tested in multiple tumor types. Coherus will share interim data Oct. 28.
Stock Titan · 14 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.